References
- 1. R. L. Prior, X. Wu and K. Schaichs, Standardized methods for the determination of antioxidant capacity and phenolics in foods and dietary supplements, J. Agric. Food Chem. 53 (2005) 4290-4302.10.1021/jf0502698
- 2. A. O. H. El-Nezhawy, M. M. Ramla, N. M. Khalifa and M. M. Abdulla, Synthesis and antioxidant activity of some thiazolidin-4-one derivatives, Monatsh. Chem. 140 (2009) 531-539; DOI: 10. 1007/s00706-008-0085-3.10.1007/s00706-008-0085-3
- 3. S. Grasso, A. Chimirri, P. Monforte and G. Fenech, Compounds with presumed antitumor activity. II. 2-Substituted 3-(2-thiazolyl)- and 3-[2-(1,3,4-thiadiazolyl)]-4-thiazolidinones, Farmaco 39 (1984) 505-513.
- 4. S. Grasso, A. Chimirri, P. Monforte, G. Fenech, M. Zappala and A. M. Monforte, Compounds with potential antitumor activity. VI. 2-Alkyl-3-[2-(1,3,4-thiadiazolyl)]-4-thiazolidinones, Farmaco43 (1988) 851-856.
- 5. A. A. Geronikaki, A. A. Lagunin, D. I. Hadjipavlou-Litina, P. T. Eleftheriou, D. A. Filimonov, V. V. Poroikov, I. Alam, and A. K. Saxena, Computer-aided discovery of anti-inflammatory thiazolidinones with dual cyclooxygenase/lipoxygenase inhibition, J. Med. Chem. 51 (2008) 1601-1609; DOI: 10.1021/jm701496h.10.1021/jm701496h
- 6. S. K. Bhati and A. Kumar, Synthesis of new substituted azetidinoyl and thiazolidinoyl-1,3,4- thiadiazino (6,5-b) indoles as promising anti-inflammatory agents, Eur. J. Med. Chem. 43 (2008) 2323-2330; DOI: 10.1016/j.ejmech.2007.10.012.10.1016/j.ejmech.2007.10.012
- 7. V. Dwivedi and R. K. Aggarwal, Synthesis and fungicidal activities of some 2-furyl-3-[(5-aryloxymethyl)-1,3,4-thiadiazol-2-yl]thiazolidin-4-ones, Asian J. Chem. 4 (1992) 780-784.
- 8. V. B. Gaur, V. H. Shah and A. R. Parikh, Studies on 4-thiazolidinones. Preparation and antimicrobial activity of 2-aryl-3-(5-o-hydroxyphenyl/p-nitrophenyl-1,3,4-thiadiazol-2-yl)-5-carboxymethyl-4-thiazolidinones, Acta Cienc. Indica Chem. 16C (1990) 437-444.
- 9. R. K. Rawal, R. Tripathi, S. B. Katti, C. Pannecouque and E. D. Clercq, Design, synthesis, and evaluation of 2-aryl-3-heteroaryl-1,3-thiazolidin-4-ones as anti-HIV agents, Bioorg. Med. Chem.15 (2007) 1725-1731; DOI: 10.1016/j.bmc.2006.12.003.10.1016/j.bmc.2006.12.003
- 10. R. K. Rawal, R. Tripathi, S. B. Katti, C. Pannecouque and E. D. Clercq, Design and synthesis of 2-(2,6-dibromophenyl)-3-heteroaryl-1,3-thiazolidin-4-ones as anti-HIV agents, Eur. J. Med. Chem. 43 (2008) 2800-2806; DOI: 10.1016/j.ejmech.2007.12.015.10.1016/j.ejmech.2007.12.015
- 11. R. K. Rawal, S. B. Katti, N. Kaushik-Basu, P. Arora and Z. Pan, Non-nucleoside inhibitors of the hepatitis C virus NS5B RNA-dependent RNA polymerase: 2-Aryl-3-heteroaryl-1,3-thiazolidin- -4-one derivatives, Bioorg. Med. Chem. Lett. 18 (2008) 6110-6114; DOI: 10.1016/j.bmcl.2008.10.02310.1016/j.bmcl.2008.10.023
- 12. A. Chimirri, S. Grasso, A. M. Monforte, M. Zappala, A. De Sarro and G. B. De Sarro, Synthesis and anticonvulsant properties of 3-(1,3,4-thiadiazol-2-yl)thiazolidin-4-ones, Farmaco 46 (1991) 935-943.
- 13. Archana, V. K. Srivastava and A. Kumar, Synthesis of newer thiadiazolyl and thiazolidinonyl quinazolin-4(3H)-ones as potential anticonvulsant agents, Eur. J. Med. Chem. 37 (2002) 873-882; DOI: 10.1016/S0223-5234(02)01389-2.10.1016/S0223-5234(02)01389-2
- 14. S. V. Bhandari, K. G. Bothara, A. A. Patil, T. S. Chitre, A. P. Sarkate, S. T. Gore, S. C. Dangre and C. V. Khachane, Design, synthesis and pharmacological screening of novel antihypertensive agents using hybrid approach, Bioorg. Med. Chem. 17 (2009) 390-400; DOI: 10.1016/j.bmc.2008. 10.032.
- 15. A. Geronikaki, P. Eleftheriou, P. Vicini, I. Alam, A. Dixit and A. K. Saxena, 2-Thiazolylimino/ heteroarylimino-5-arylidene-4-thiazolidinones as new agents with SHP-2 inhibitory action, J. Med. Chem. 51 (2008) 5221-5228; DOI: 10.1021/jm8004306.10.1021/jm800430618702480
- 16. N. S. Cutshall, C. O’Day and M. Prezhdo, Rhodanine derivatives as inhibitors of JSP-1, Bioorg. Med. Chem. Lett. 15 (2005) 3374-3379.10.1016/j.bmcl.2005.05.03415961311
- 17. P. H. Carter, P. A. Scherle, J. A. Muckelbauer, M. E. Voss, R. Q. Liu, L. A. Thompson, A. J. Tebben, K. A. Solomon, Y. C. Lo, Z. Li, P. Strzemienski, G. Yang, N. Falahatpisheh, M. Xu, Z. Wu, N.A. Farrow, K. Ramnarayan, J. Wang, D. Rideout, V. Yalamoori, P. Domaille, D. J. Underwood, J. M. Trzaskos, S. M. Friedman, R. C. Newton and C. P. Decicco, Photochemically enhanced binding of small molecules to the tumor necrosis factor receptor-1 inhibits the binding of TNF-alpha, Proc. Natl. Acad. Sci. USA 98 (2001) 11879-11884.10.1073/pnas.211178398
- 18. A. Degterev, A. Lugovskoy, M. Cardone, B. Mulley, G. Wagner, T. Mitchison and J. Yuan, Identification of small-molecule inhibitors of interaction between the BH3 domain and Bcl-xl, Nat. Cell Biol. 3 (2001) 173-182.10.1038/35055085
- 19. R. Dayam, F. Aiello, J. Deng, Y. Wu, A. Garofalo, X. Chen and N. Neamati, Discovery of small molecule integrin avb3 antagonists as novel anticancer agents, J. Med. Chem. 49 (2006) 4526-4534; DOI: 10.1021/jm051296s.10.1021/jm051296s
- 20. A. Senff-Ribeiro, A. Echevarria, E. F. Silva, S. S. Veiga and M. B. Oliveira, Antimelanoma activity of 1,3,4-thiadiazolium mesoionics: a structure-activity relationship study, Anticancer Drugs15 (2004) 269-275.
- 21. R. F. Asbury, J. A. Blessing and D. Moore, A phase II trail of aminothiadiazole in patients with mixed mesodermal tumors of the uterine corpus: a gynecologic oncology group study, Am. J. Clin. Oncol. 19 (1996) 400-402.
- 22. J. Y. Chou, S. Y. Lai, S. L. Pan, G. M. Jow, J. W. Chern and J. H. Guh, Investigation of anticancer mechanism of thiadiazole-based compound in human non-small cell lung cancer A549 cells, Biochem. Pharmacol. 66 (2003) 115-124; DOI: 10.1016/S0006-2952(03)00254-5.10.1016/S0006-2952(03)00254-5
- 23. S. K. Suthar, V. Jaiswal, S. Lohan, S. Bansal, A. Chaudhary, A. Tiwari, A. T. Alex and A. Joseph, Novel quinolone substituted thiazolidin-4-ones as anti-inflammatory, anticancer agents: Design, synthesis and biological screening, Eur. J. Med Chem. 63 (2013) 589-602; DOI: 10.1016/j. ejmech.2013.03.011.
- 24. P. Mishra, V. Jatav and S. K. Kashaw, Some novel 2-methyl-3-(1’3’4’-thiazolyl)-4-(3H)quinazolinones with anticonvulsant and CNS depressant activity, J. Indian Chem. Soc. 83 (2006) 1165-1170.
- 25. C. V. Kavitha, Basappa, S. N. Swamy, K. Mantelingu, S. Doreswamy, M. A. Sridhar, J. S. Prasad and K. K. S. Rangappa, Synthesis of new bioactive venlafaxine analogs: Novel thiazolidin-4- ones as antimicrobials, Bioorg. Med. Chem. 14 (2006) 2290-2299; DOI: 10.1016/j.bmc.2005.11.017.10.1016/j.bmc.2005.11.01716338140
- 26. L. L. Mensor, F. S. Menzes, G. G. Leitao, A. S. Reis, T. C. Dosantos, C. S. Coube and S. G. Leitao, Screening of Brazilian extract for antioxidant activity by the DPPH free radical method, Phytother. Res. 15 (2001) 127-130; DOI: 10.1002/ptr.687.10.1002/ptr.68711268111
- 27. T. Mosmann, Rapid colorimetric assay for cellular growth and survival: Application to proliferation and cytotoxicity assays, J. Immunol. Methods 65 (1983) 55-63; DOI: 10.1016/0022-1759(83) 90303-4.